Coronary Stents Market Report: Drivers, Restraints and Opportunities, Trends and Forecasts to 2023
Indian Market Scenario for Coronary Stent
Cardiovascular diseases account for closely 25% of the deaths in India among the age group of 25 and 70 years. The total number of percutaneous coronary interventions (PCI) is growing gradually at a mid CAGR. In 2016, 495,000 PCI procedures were carried out in India, using 594,000 stents (with an average of 1.2 stents per procedure). Out of these, 80% of the procedures performed used drug-eluting stents (DES), with over 60% of the stents being imported. These MNCs classically go through a supply chain, where the distributors manage the procurement and storage of the stents, and later ship them to the hospitals on requirement. The hospitals add their share of profit to the procured price and bill accordingly. This led to a wide gap between the actual cost of the stent and the selling price to the patient. The average selling price (ASP) of a bare metal stent (BMS) used to be as high as Rs.45,000 ($670) and the drug-eluting stents were priced more than Rs.120,000 ($1,800). This generated a profit between 270% to 1,000%.
Ceiling fixed prices for coronary stents
The notification by National Pharmaceutical Pricing Policy categorizes the stents into bare metal stents (BMS) and drug-eluting stents (DES). Bare metal stents are not to be priced more than Rs.7,260 ($110), while drug-eluting stents should be priced below Rs.29,600 ($450). This is 40% lesser than the previous prices.
Manufacturer Brand Prices (Rs)
Abbott Laboratories Aborb/ Absorb GT1 31,689
Abbott Laboratories Xience Alpine 31,689
Abbott Laboratories Xience Prime 24,675
Abbott Laboratories Xience Pro 24,675
Abbott Laboratories Xience V 24,675
Abbott Laboratories Xience Xpedition 31,689
Boston Scientific Corporation Promus Element
Boston Scientific Corporation Promus Premier 31,689
Boston Scientific Corporation Synergy 31,689
Meril Life Science Biomime 23,625
Sahajanand Medical Technologies Supraflex 23,289
Biotronik Orsiro 31,689
Vascular Concept Limited Pronova XR 31,689
Does this also include imported stents?
The notification makes no discrepancy between branded or unbranded stents, locally manufactured or imported stents. Any stent sold in the Indian market cannot be charged more than Rs.29,600 ($450), though there is the addition of local taxes to these prices. The manufacturers with higher selling price than the cap will have to reduce the prices of their stents, while those selling at lesser prices should maintain their original MRP.
Indian Market Scenario
The Indian coronary stent market is worth currently around $500 million and is anticipated to grow many times in the future due to the growing number of diabetes and hypertension cases. International stent manufacturers, who hold around 60% of the market, are unhappy with the price capping. Hence, they are planning to with withdraw their advanced products from the Indian market and are planning not to bring in the new-generation products in the future. This change may affect the procedural outcomes, especially in complex cases. Thus, India is expected to face more challenges in the future. Abbott requested the removal of its Alpine and Absorb stents from the Indian market, while Medtronic requested to withdraw its Onyx stents. Following them, Boston petitioned for the removal of synergy stents. But their request was rejected by the Indian authorities. This has given a better opportunity for the domestic manufacturers to increase their market share which currently hold less than 40% share.
Regulatory changes for price control
The coronary stents market is segmented into bare metal stents, drug-eluting stents, and bioabsorbable stents. Approximately 90% of all the percutaneous coronary intervention (PCI) surgeries use a coronary stent. Thus, drug-eluting stents hold the major share in the market. The highest growth rate is expected in the bioresorbable stents due to the advantages of the polylactic acid material. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the Global Coronary Stents Market.
The exit of Johnson and Johnson from the coronary stents market has provided an opportunity for many players to strengthen their market share. Abbott Laboratories, Medtronic, and Boston Scientific Corporation are the market leaders in the global coronary stents market in 2016. The top three market players are estimated to hold more than 60% share of the market in 2016. Abbott Laboratories emerged to be the global leader, while Boston Scientific Corporation dominated the market in Brazil and other emerging Latin American countries.
Global coronary stents market growth
The Global Coronary Stents Market is expected to grow at a CAGR of 6.1% during the forecast period 2017–2023. The market is analyzed based on regions and verticals. The market in emerging regions, mergers and acquisitions, and the increase in clinical trials are some factors providing opportunities for the market growth during the forecast period.
Cardiovascular diseases account for closely 25% of the deaths in India among the age group of 25 and 70 years. The total number of percutaneous coronary interventions (PCI) is growing gradually at a mid CAGR. In 2016, 495,000 PCI procedures were carried out in India, using 594,000 stents (with an average of 1.2 stents per procedure). Out of these, 80% of the procedures performed used drug-eluting stents (DES), with over 60% of the stents being imported. These MNCs classically go through a supply chain, where the distributors manage the procurement and storage of the stents, and later ship them to the hospitals on requirement. The hospitals add their share of profit to the procured price and bill accordingly. This led to a wide gap between the actual cost of the stent and the selling price to the patient. The average selling price (ASP) of a bare metal stent (BMS) used to be as high as Rs.45,000 ($670) and the drug-eluting stents were priced more than Rs.120,000 ($1,800). This generated a profit between 270% to 1,000%.
Ceiling fixed prices for coronary stents
The notification by National Pharmaceutical Pricing Policy categorizes the stents into bare metal stents (BMS) and drug-eluting stents (DES). Bare metal stents are not to be priced more than Rs.7,260 ($110), while drug-eluting stents should be priced below Rs.29,600 ($450). This is 40% lesser than the previous prices.
Manufacturer Brand Prices (Rs)
Abbott Laboratories Aborb/ Absorb GT1 31,689
Abbott Laboratories Xience Alpine 31,689
Abbott Laboratories Xience Prime 24,675
Abbott Laboratories Xience Pro 24,675
Abbott Laboratories Xience V 24,675
Abbott Laboratories Xience Xpedition 31,689
Boston Scientific Corporation Promus Element
Boston Scientific Corporation Promus Premier 31,689
Boston Scientific Corporation Synergy 31,689
Meril Life Science Biomime 23,625
Sahajanand Medical Technologies Supraflex 23,289
Biotronik Orsiro 31,689
Vascular Concept Limited Pronova XR 31,689
Does this also include imported stents?
The notification makes no discrepancy between branded or unbranded stents, locally manufactured or imported stents. Any stent sold in the Indian market cannot be charged more than Rs.29,600 ($450), though there is the addition of local taxes to these prices. The manufacturers with higher selling price than the cap will have to reduce the prices of their stents, while those selling at lesser prices should maintain their original MRP.
Indian Market Scenario
The Indian coronary stent market is worth currently around $500 million and is anticipated to grow many times in the future due to the growing number of diabetes and hypertension cases. International stent manufacturers, who hold around 60% of the market, are unhappy with the price capping. Hence, they are planning to with withdraw their advanced products from the Indian market and are planning not to bring in the new-generation products in the future. This change may affect the procedural outcomes, especially in complex cases. Thus, India is expected to face more challenges in the future. Abbott requested the removal of its Alpine and Absorb stents from the Indian market, while Medtronic requested to withdraw its Onyx stents. Following them, Boston petitioned for the removal of synergy stents. But their request was rejected by the Indian authorities. This has given a better opportunity for the domestic manufacturers to increase their market share which currently hold less than 40% share.
Regulatory changes for price control
- In July 2016, the coronary stents were included in the National List of Essential Medicines, 2015 (NLEM, 2015) by the Ministry of Health and Family Welfare.
- In December 2016, the coronary stents were given the status of scheduled formulation as in the Drug Price Control Order 2013, by the Department of Pharmaceuticals.
The coronary stents market is segmented into bare metal stents, drug-eluting stents, and bioabsorbable stents. Approximately 90% of all the percutaneous coronary intervention (PCI) surgeries use a coronary stent. Thus, drug-eluting stents hold the major share in the market. The highest growth rate is expected in the bioresorbable stents due to the advantages of the polylactic acid material. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the Global Coronary Stents Market.
The exit of Johnson and Johnson from the coronary stents market has provided an opportunity for many players to strengthen their market share. Abbott Laboratories, Medtronic, and Boston Scientific Corporation are the market leaders in the global coronary stents market in 2016. The top three market players are estimated to hold more than 60% share of the market in 2016. Abbott Laboratories emerged to be the global leader, while Boston Scientific Corporation dominated the market in Brazil and other emerging Latin American countries.
Global coronary stents market growth
The Global Coronary Stents Market is expected to grow at a CAGR of 6.1% during the forecast period 2017–2023. The market is analyzed based on regions and verticals. The market in emerging regions, mergers and acquisitions, and the increase in clinical trials are some factors providing opportunities for the market growth during the forecast period.
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Peripheral Vascular Stents
3.3.3 Atherectomy
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Causes for Coronary Heart Disease
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Stents Platforms
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing prevalence of cardiovascular diseases
5.3.1.2 Increasing aging population
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 High cost of treatment associated with stent implants
5.3.3.3 Availability of alternative treatment procedure
5.4 DRO – Impact Analysis
5.5 Key Stakeholders
6 CORONARY STENTS PIPELINE
6.1 Overview
7 TYPES: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bare Metal Stents (BMS)
7.3 Drug Eluting Stents
7.4 Bio-absorbable Stents
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Cardiac Centers
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Rest of the World
9.5.1 Africa
9.5.2 Brazil
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDORS PROFILE
11.1 Abbott Laboratories (Abbott)
11.1.1 Overview
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Boston Scientific Corp. (Boston)
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 B. Braun Melsungen AG
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Medtronic Plc
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 MicroPort Scientific Corporation
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Terumo Corp.
12.1.1 Overview
12.2 Biosensors International Group
12.2.1 Overview
12.3 BIOTRONIK
12.3.1 Overview
12.4 Meril Life Science
12.4.1 Overview
12.5 STENTYS S.A.
12.5.1 Overview
12.5.2 Overview
Annexure
Abbreviations
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Peripheral Vascular Stents
3.3.3 Atherectomy
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Causes for Coronary Heart Disease
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Stents Platforms
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing prevalence of cardiovascular diseases
5.3.1.2 Increasing aging population
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 High cost of treatment associated with stent implants
5.3.3.3 Availability of alternative treatment procedure
5.4 DRO – Impact Analysis
5.5 Key Stakeholders
6 CORONARY STENTS PIPELINE
6.1 Overview
7 TYPES: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bare Metal Stents (BMS)
7.3 Drug Eluting Stents
7.4 Bio-absorbable Stents
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Cardiac Centers
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Rest of the World
9.5.1 Africa
9.5.2 Brazil
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDORS PROFILE
11.1 Abbott Laboratories (Abbott)
11.1.1 Overview
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Boston Scientific Corp. (Boston)
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 B. Braun Melsungen AG
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Medtronic Plc
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 MicroPort Scientific Corporation
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Terumo Corp.
12.1.1 Overview
12.2 Biosensors International Group
12.2.1 Overview
12.3 BIOTRONIK
12.3.1 Overview
12.4 Meril Life Science
12.4.1 Overview
12.5 STENTYS S.A.
12.5.1 Overview
12.5.2 Overview
Annexure
Abbreviations
Charts
Chart 1 PEST ANALYSIS OF GLOBAL CORONARY STENTS MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL CORONARY STENTS MARKET
Chart 3 GLOBAL CORONARY STENTS MARKET REVENUE FORECAST, 2016–2023 ($MILLION)
Chart 4 GLOBAL CORONARY STENTS MARKET SEGMENTATION
Chart 5 PORTER 5 FORCES ON GLOBAL CORONARY STENTS MARKET
Chart 6 MARKET DYNAMICS – DRO ANALYSIS
Chart 7 DRO – IMPACT ANALYSIS OF GLOBAL CORONARY STENTS MARKET
Chart 8 KEY STAKEHOLDERS
Chart 9 GLOBAL CORONARY STENTS MARKET BY TYPE SEGMENTATION, 2023 (%)
Chart 10 GLOBAL BARE METAL STENTS (BMS) MARKET REVENUE FORECAST, 2016–2023 ($MILLION)
Chart 11 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, 2016-2023 ($MILLION)
Chart 12 GLOBAL BIO-ABSORBABLE STENTS MARKET REVENUE, 2016-2023 ($MILLION)
Chart 13 GLOBAL CORONARY STENTS MARKET BY END-USER SEGMENTATION, 2016 VS 2023 (%)
Chart 14 GLOBAL CORONARY STENTS MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 15 CORONARY STENTS MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 16 CORONARY STENTS MARKET REVENUE IN THE EUROPE REGION, 2016–2023 ($MILLION)
Chart 17 CORONARY STENTS MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION)
Chart 18 CORONARY STENTS MARKET REVENUE IN THE REST OF THE WORLD REGION, 2016–2023 ($MILLION)
Chart 19 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT
Chart 20 ABBOTT LABORATORIES.: BUSINESS UNITS
Chart 21 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
Chart 22 ABBOTT LABORATORIES.: SWOT ANALYSIS
Chart 23 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 24 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS
Chart 25 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 26 BOSTON SCIENTIFIC CORP: SWOT ANALYSIS
Chart 27 B. BRAUN MELSUNGEN AG: OVERVIEW SNAPSHOT
Chart 28 B. BRAUN MELSUNGEN AG BUSINESS UNITS
Chart 29 B. BRAUN MELSUNGEN AG: GEOGRAPHIC PRESENCE
Chart 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
Chart 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 32 MEDTRONIC PLC: BUSINESS UNITS
Chart 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 34 MEDTRONIC PLC: SWOT ANALYSIS
Chart 35 MICROPORT SCIENTIFIC CORPORATION: OVERVIEW SNAPSHOT
Chart 36 MICROPORT SCIENTIFIC CORPORATION: BUSINESS UNITS
Chart 37 MICROPORT SCIENTIFIC CORPORATION: GEOGRAPHIC PRESENCE
Chart 38 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Peripheral Vascular Stents
3.3.3 Atherectomy
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Causes for Coronary Heart Disease
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Stents Platforms
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing prevalence of cardiovascular diseases
5.3.1.2 Increasing aging population
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 High cost of treatment associated with stent implants
5.3.3.3 Availability of alternative treatment procedure
5.4 DRO – Impact Analysis
5.5 Key Stakeholders
6 CORONARY STENTS PIPELINE
6.1 Overview
7 TYPES: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bare Metal Stents (BMS)
7.3 Drug Eluting Stents
7.4 Bio-absorbable Stents
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Cardiac Centers
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Rest of the World
9.5.1 Africa
9.5.2 Brazil
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDORS PROFILE
11.1 Abbott Laboratories (Abbott)
11.1.1 Overview
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Boston Scientific Corp. (Boston)
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 B. Braun Melsungen AG
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Medtronic Plc
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 MicroPort Scientific Corporation
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Terumo Corp.
12.1.1 Overview
12.2 Biosensors International Group
12.2.1 Overview
12.3 BIOTRONIK
12.3.1 Overview
12.4 Meril Life Science
12.4.1 Overview
12.5 STENTYS S.A.
12.5.1 Overview
12.5.2 Overview
Annexure
Abbreviations
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Peripheral Vascular Stents
3.3.3 Atherectomy
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Causes for Coronary Heart Disease
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Stents Platforms
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing prevalence of cardiovascular diseases
5.3.1.2 Increasing aging population
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 High cost of treatment associated with stent implants
5.3.3.3 Availability of alternative treatment procedure
5.4 DRO – Impact Analysis
5.5 Key Stakeholders
6 CORONARY STENTS PIPELINE
6.1 Overview
7 TYPES: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bare Metal Stents (BMS)
7.3 Drug Eluting Stents
7.4 Bio-absorbable Stents
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Cardiac Centers
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.5 Rest of the World
9.5.1 Africa
9.5.2 Brazil
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDORS PROFILE
11.1 Abbott Laboratories (Abbott)
11.1.1 Overview
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Boston Scientific Corp. (Boston)
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 B. Braun Melsungen AG
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Medtronic Plc
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 MicroPort Scientific Corporation
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Terumo Corp.
12.1.1 Overview
12.2 Biosensors International Group
12.2.1 Overview
12.3 BIOTRONIK
12.3.1 Overview
12.4 Meril Life Science
12.4.1 Overview
12.5 STENTYS S.A.
12.5.1 Overview
12.5.2 Overview
Annexure
Abbreviations
Charts
Chart 1 PEST ANALYSIS OF GLOBAL CORONARY STENTS MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL CORONARY STENTS MARKET
Chart 3 GLOBAL CORONARY STENTS MARKET REVENUE FORECAST, 2016–2023 ($MILLION)
Chart 4 GLOBAL CORONARY STENTS MARKET SEGMENTATION
Chart 5 PORTER 5 FORCES ON GLOBAL CORONARY STENTS MARKET
Chart 6 MARKET DYNAMICS – DRO ANALYSIS
Chart 7 DRO – IMPACT ANALYSIS OF GLOBAL CORONARY STENTS MARKET
Chart 8 KEY STAKEHOLDERS
Chart 9 GLOBAL CORONARY STENTS MARKET BY TYPE SEGMENTATION, 2023 (%)
Chart 10 GLOBAL BARE METAL STENTS (BMS) MARKET REVENUE FORECAST, 2016–2023 ($MILLION)
Chart 11 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, 2016-2023 ($MILLION)
Chart 12 GLOBAL BIO-ABSORBABLE STENTS MARKET REVENUE, 2016-2023 ($MILLION)
Chart 13 GLOBAL CORONARY STENTS MARKET BY END-USER SEGMENTATION, 2016 VS 2023 (%)
Chart 14 GLOBAL CORONARY STENTS MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 15 CORONARY STENTS MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 16 CORONARY STENTS MARKET REVENUE IN THE EUROPE REGION, 2016–2023 ($MILLION)
Chart 17 CORONARY STENTS MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION)
Chart 18 CORONARY STENTS MARKET REVENUE IN THE REST OF THE WORLD REGION, 2016–2023 ($MILLION)
Chart 19 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT
Chart 20 ABBOTT LABORATORIES.: BUSINESS UNITS
Chart 21 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
Chart 22 ABBOTT LABORATORIES.: SWOT ANALYSIS
Chart 23 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 24 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS
Chart 25 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 26 BOSTON SCIENTIFIC CORP: SWOT ANALYSIS
Chart 27 B. BRAUN MELSUNGEN AG: OVERVIEW SNAPSHOT
Chart 28 B. BRAUN MELSUNGEN AG BUSINESS UNITS
Chart 29 B. BRAUN MELSUNGEN AG: GEOGRAPHIC PRESENCE
Chart 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
Chart 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 32 MEDTRONIC PLC: BUSINESS UNITS
Chart 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 34 MEDTRONIC PLC: SWOT ANALYSIS
Chart 35 MICROPORT SCIENTIFIC CORPORATION: OVERVIEW SNAPSHOT
Chart 36 MICROPORT SCIENTIFIC CORPORATION: BUSINESS UNITS
Chart 37 MICROPORT SCIENTIFIC CORPORATION: GEOGRAPHIC PRESENCE
Chart 38 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS
